biote Corp.
BTMD
$1.44
$0.085.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 192.22M | 195.65M | 199.07M | 199.38M | 197.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 192.22M | 195.65M | 199.07M | 199.38M | 197.19M |
| Cost of Revenue | 54.86M | 54.06M | 55.80M | 57.29M | 58.13M |
| Gross Profit | 137.36M | 141.58M | 143.27M | 142.09M | 139.06M |
| SG&A Expenses | 103.91M | 105.87M | 103.32M | 106.28M | 102.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 158.77M | 159.93M | 159.12M | 163.57M | 160.64M |
| Operating Income | 33.45M | 35.71M | 39.95M | 35.81M | 36.55M |
| Income Before Tax | 37.58M | 30.76M | 38.17M | 21.80M | 1.02M |
| Income Tax Expenses | 5.99M | -1.70M | 2.26M | 184.00K | 970.00K |
| Earnings from Continuing Operations | 31.60 | 32.46 | 35.90 | 21.61 | 0.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.55M | -3.67M | -4.60M | -575.00K | 3.11M |
| Net Income | 27.05M | 28.79M | 31.31M | 21.04M | 3.16M |
| EBIT | 33.45M | 35.71M | 39.95M | 35.81M | 36.55M |
| EBITDA | 35.92M | 38.17M | 42.17M | 37.99M | 38.52M |
| EPS Basic | 0.86 | 0.92 | 1.00 | 0.68 | 0.13 |
| Normalized Basic EPS | 0.32 | 0.41 | 0.44 | 0.48 | 0.62 |
| EPS Diluted | 0.75 | 0.79 | 0.90 | 0.59 | 0.10 |
| Normalized Diluted EPS | 0.29 | 0.37 | 0.40 | 0.45 | 0.60 |
| Average Basic Shares Outstanding | 125.14M | 125.73M | 125.44M | 126.88M | 130.02M |
| Average Diluted Shares Outstanding | 136.23M | 142.70M | 138.25M | 139.58M | 137.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 5.88% | 5.52% | 6.50% | 21.74% | 147.48% |